Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance.

Mediterr J Hematol Infect Dis · 2019 · PMC6328037 · PMID 30671213

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

During recent follow up on monthly bortezomib treatment, her proteinuria showed an increasing trend up to 1 g/day, and the bortezomib maintenance therapy frequency was switched back to once every three weeks.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.